IP Library › Granted Patent US 10,226,496
Granted Patent B2
US 10,226,496 · App. 15/914,064 · Granted Mar 12, 2019

Topical treatments incorporating

Inventors: Ronald D. Sekura (Key Largo, FL); Roscoe M. Moore (Rockville, MD)
A61K36/185A61K8/498A61K9/0014A61K9/0034A61K9/0043A61K9/06A61K9/08A61K31/045A61K31/047A61K31/05A61K31/085A61K31/12A61K31/235A61K31/245A61K31/352A61K31/573A61K31/618A61K36/00A61K36/61A61K45/06A61K47/12A61K47/44A61P17/06A61Q5/006A61Q5/02A61Q19/00A61Q19/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,496
App. No.
15/914,064
Granted
Mar 12, 2019
Kind
B2
Abstract

A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of tetrahydrocannabinol, cannabidiol, or both in the topical formulation is greater than 2 milligrams per kilogram.

Claims (15)

1. A topical formulation, consisting essentially of:

an extract of cannabis sativa or cannabis indica ; and

at least one component selected from the group consisting of benzoyl peroxide, oxybenzone, octocrylene, octyl methoxycinnamate, ethylhexyl salicylate, and avobenzone, present in an amount of at least 0.1 wt % in the topical formulation,

wherein a concentration of at least one selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is greater than 2 milligrams per kilogram, and

wherein the topical formulation is obtained by dispersing the extract of cannabis sativa or cannabis indica in a water-in-oil emulsion, an oil-in-water emulsion, a wax-in-oil base, an oil-in-wax base, or a liniment consisting essentially of the at least one component selected from the group consisting of benzoyl peroxide, oxybenzone, octocrylene, octyl methoxycinnamate, ethylhexyl salicylate, and avobenzone.

2. The topical formulation of claim 1 , wherein the extract is an extract of cannabis sativa.

3. The topical formulation of claim 1 , wherein the extract is an extract of cannabis indica.

4. The topical formulation of claim 1 , wherein the concentration of the at least one selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is from 2 to 100 milligrams per kilogram.

5. The topical formulation of claim 1 , wherein the concentration of the at least one selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is from 2 to 25 milligrams per kilogram.

6. The topical formulation of claim 1 , wherein said component is benzoyl peroxide.

7. The topical formulation of claim 1 , wherein said component is oxybenzone.

8. The topical formulation of claim 1 , wherein said component is octocrylene.

9. The topical formulation of claim 1 , wherein said component is octyl methoxycinnamate.

10. The topical formulation of claim 1 , wherein said component is ethylhexyl salicylate.

11. The topical formulation of claim 1 , wherein said component is avobenzone.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2024
From: SEKURA, RONALD D.; MOORE, ROSCOE M.
To: METRONOME LLC
Reel/Frame 067795/0760 →
Continuity (4)
Continuation 14750558 · Jun 25, 2015
Continuation 14498555 · Sep 26, 2014
Provisional Application 61882990 · Sep 26, 2013
Related Publication 20180193394A1 · Jul 12, 2018
Cited By (1)
US 12,447,192